These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11036157)

  • 21. Nitration of soluble proteins in organotypic culture models of Parkinson's disease.
    Larsen TR; Söderling AS; Caidahl K; Roepstorff P; Gramsbergen JB
    Neurochem Int; 2008 Feb; 52(3):487-94. PubMed ID: 17900761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons.
    Lotharius J; Dugan LL; O'Malley KL
    J Neurosci; 1999 Feb; 19(4):1284-93. PubMed ID: 9952406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immortalized dopamine neurons: A model to study neurotoxicity and neuroprotection.
    Clarkson ED; Edwards-Prasad J; Freed CR; Prasad KN
    Proc Soc Exp Biol Med; 1999 Nov; 222(2):157-63. PubMed ID: 10564540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: effect of 1-methyl-4-phenylpyridinium treatment.
    Beck KD; Knusel B; Pasinetti G; Michel PP; Zawadzka H; Goldstein M; Hefti F
    J Neurochem; 1991 Aug; 57(2):527-32. PubMed ID: 1677030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease.
    Peng J; Stevenson FF; Doctrow SR; Andersen JK
    J Biol Chem; 2005 Aug; 280(32):29194-8. PubMed ID: 15946937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats.
    Wang JY; Wu JN; Cherng TL; Hoffer BJ; Chen HH; Borlongan CV; Wang Y
    Brain Res; 2001 Jun; 904(1):67-75. PubMed ID: 11516412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage-dependent vulnerability of fetal mesencephalic neuroprogenitors towards dopaminergic neurotoxins.
    Sabolek M; Mieskes I; Lenk T; Lehmensiek V; Hermann A; Schwarz J; Storch A
    Neurotoxicology; 2008 Jul; 29(4):714-21. PubMed ID: 18513801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel peptide inhibitor targeted to caspase-3 cleavage site of a proapoptotic kinase protein kinase C delta (PKCdelta) protects against dopaminergic neuronal degeneration in Parkinson's disease models.
    Kanthasamy AG; Anantharam V; Zhang D; Latchoumycandane C; Jin H; Kaul S; Kanthasamy A
    Free Radic Biol Med; 2006 Nov; 41(10):1578-89. PubMed ID: 17045926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration.
    Kaul S; Kanthasamy A; Kitazawa M; Anantharam V; Kanthasamy AG
    Eur J Neurosci; 2003 Sep; 18(6):1387-401. PubMed ID: 14511319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue.
    Andres RH; Huber AW; Schlattner U; Pérez-Bouza A; Krebs SH; Seiler RW; Wallimann T; Widmer HR
    Neuroscience; 2005; 133(3):701-13. PubMed ID: 15890457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effect of rotigotine against complex I inhibitors, MPP⁺ and rotenone, in primary mesencephalic cell culture.
    Radad K; Scheller D; Rausch WD; Reichmann H; Gille G
    Folia Neuropathol; 2014; 52(2):179-86. PubMed ID: 25118903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.
    Park TH; Mytilineou C
    Brain Res; 1992 Dec; 599(1):83-97. PubMed ID: 1362921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
    Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
    J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
    Carrasco E; Casper D; Werner P
    J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection by BTCP of cultured dopaminergic neurons exposed to neurotoxins.
    Cerruti C; Drian MJ; Kamenka JM; Privat A
    Brain Res; 1993 Jul; 617(1):138-42. PubMed ID: 8104081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effects of riluzole on dopamine neurons: involvement of oxidative stress and cellular energy metabolism.
    Storch A; Burkhardt K; Ludolph AC; Schwarz J
    J Neurochem; 2000 Dec; 75(6):2259-69. PubMed ID: 11080177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture: selectivity and irreversibility.
    Michel PP; Dandapani BK; Knusel B; Sanchez-Ramos J; Hefti F
    J Neurochem; 1990 Apr; 54(4):1102-9. PubMed ID: 1968953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
    Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
    Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective destruction of dopaminergic neurons by low concentrations of 6-OHDA and MPP+: protection by acetylsalicylic acid aspirin.
    Carrasco E; Werner P
    Parkinsonism Relat Disord; 2002 Sep; 8(6):407-11. PubMed ID: 12217628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro.
    Huang JY; Hong YT; Chuang JI
    J Neurochem; 2009 Jun; 109(5):1400-12. PubMed ID: 19476551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.